This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.63% per year. These returns cover a period from January 1, 1988 through December 2, 2019. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Helen of Troy (HELE) Gains on Leadership Brands, Hurt by Costs
by Zacks Equity Research
Helen of Troy (HELE) is benefiting from its solid Leadership Brands and a focus on Project Pegasus, while escalated costs and softness in the Beauty segment are concerns.
Monster Beverage (MNST) Rises 30% in a Year: More Upside Left?
by Zacks Equity Research
Despite elevated costs and currency woes, Monster Beverage's (MNST) continued momentum in the energy drinks category and a robust pipeline of new products are likely to drive growth.
Altria's (MO) Smoke-Free Products Aid Amid Low Cigarette Volume
by Zacks Equity Research
Altria (MO) has been benefiting from its Oral Tobacco Products and strong pricing power. However, soft volumes in the Smokeable Products segment are a concern.
General Mills (GIS) Raises Guidance Again on Q3 Earnings Beat
by Zacks Equity Research
General Mills' (GIS) third-quarter fiscal 2023 results reflect solid earnings and sales, leading to raised guidance. The company focuses on its Accelerate strategy.
Conagra Brands' (CAG) Pricing Efforts Bode Well Amid Cost Woes
by Zacks Equity Research
Conagra Brands' (CAG) robust pricing endeavors have been aiding the company amid cost headwinds. A focus on innovation has also been a driver.
Vital Farms (VITL) Misses Q4 Earnings Estimates
by Zacks Equity Research
Vital Farms (VITL) delivered earnings and revenue surprises of -20% and 4.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Vital Farms (VITL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Vital Farms (VITL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's How AB InBev (BUD) Looks Just Ahead of Q4 Earnings
by Zacks Equity Research
AB InBev (BUD) Q4 results are expected to reflect gains from continued business momentum, premiumization and digital growth, offset by adverse currency rates, commodity costs and supply-chain costs.
The J.M. Smucker (SJM) Readies for Q3 Earnings: Things to Note
by Zacks Equity Research
The J.M. Smucker's (SJM) third-quarter results are likely to reflect the adverse impacts of cost inflation, while pricing efforts and strength in the coffee business bode well.
Inter Parfums (IPAR) Queued for Q4 Earnings: Things to Note
by Zacks Equity Research
Inter Parfums' (IPAR) fourth-quarter 2022 performance will likely reflect solid sales, owing to higher U.S.-based and Europe-based product sales.
Know What's in Store for Monster Beverage (MNST) in Q4 Earnings
by Zacks Equity Research
Monster Beverage (MNST) Q4 results are expected to reflect gains from strength in the energy drinks business, continued pricing actions to wean inflationary costs and product innovation.
Medifast (MED) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Medifast (MED) delivered earnings and revenue surprises of 69.72% and 9.96%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Beyond Meat (BYND) in Q4 Earnings?
by Zacks Equity Research
Beyond Meat's (BYND) fourth-quarter 2022 performance is likely to reflect the impact of higher inflation. Nevertheless, its focus on curtailing operating expenses is an upside.
Why FEMSA (FMX) Looks Poised for an Earnings Beat in Q4
by Zacks Equity Research
FEMSA's (FMX) Q4 results are expected to reflect gains from strong demand, growth in the digital business and expansion into the specialized distribution industry.
Things to Support Molson Coors' (TAP) Earnings Beat in Q4
by Zacks Equity Research
Molson Coors' (TAP) Q4 results are expected to reflect the benefits of pricing actions, the revitalization plan and the premiumization of its global portfolio.
Aramark (ARMK) Q1 Earnings Miss Estimates
by Zacks Equity Research
Aramark (ARMK) delivered earnings and revenue surprises of -2.38% and 1.78%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Strength Seen in Vital Farms (VITL): Can Its 6.8% Jump Turn into More Strength?
by Zacks Equity Research
Vital Farms (VITL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Beat the Market Like Zacks: JPMorgan Chase, Oracle, BioVie in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Vital Farms (VITL) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Vital Farms (VITL) delivered earnings and revenue surprises of 100% and 3.81%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include Vital Farms, Coupang and Webster Financial
by Zacks Equity Research
Vital Farms, Coupang and Webster Financial are part of the Zacks Screen of the Week article.
Buy 3 of the Best Stocks for Earnings Acceleration
by Tirthankar Chakraborty
Invest in stocks like Vital Farms (VITL), Coupang (CPNG) and Webster Financial (WBS) at the moment for superb earnings acceleration.
Chefs' Warehouse (CHEF) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Chefs' Warehouse (CHEF) delivered earnings and revenue surprises of 51.85% and 8.39%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for Vital Farms (VITL) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Vital Farms (VITL) stock based on the movements in the options market lately.
Vital Farms (VITL) Reports Break-Even Earnings for Q2
by Zacks Equity Research
Vital Farms (VITL) delivered earnings and revenue surprises of 100% and 4.22%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Darling Ingredients (DAR) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Darling (DAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.